Should a statin be given to all hypertensive patients?
Statins have become an essential treatment for primary and secondary prevention of cardiovascular risk. This has been firmly established for patients with a relatively high risk for cardiovascular complications. Recent studies, in particular the HOPE trial, has extended this observation to patients...
Main Author: | Harry Struijker-Boudier |
---|---|
Format: | Article |
Language: | English |
Published: |
Atlantis Press
2017-04-01
|
Series: | Artery Research |
Subjects: | |
Online Access: | https://www.atlantis-press.com/article/125924985/view |
Similar Items
-
Statins in arterial hypertension treatment
by: O. N. Tkacheva, et al.
Published: (1970-01-01) -
Statins: Not all are benefits
by: Isabel García Cuerda, et al.
Published: (2018-10-01) -
Influence of the statin therapy on cardiovascular remodeling in arterial hypertension, combined with subclinical hypothyroidism
by: Ye. V. Novikov, et al.
Published: (2020-12-01) -
SHOULD STATINS BE DISCONTINUED IN PERI-OPERATIVE PERIOD?
by: V. V. Lomivorotov, et al.
Published: (2018-08-01) -
Statins associated diabetes: state of the problem in 2018
by: Zh. D. Kobalava, et al.
Published: (2018-09-01)